EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

How Do Gepotidacin and Zoliflodacin Stabilize DNA Cleavage Complexes with Bacterial Type IIA Topoisomerases? 1. Experimental Definition of Metal Binding Sites

Harry Morgan iD, Robert A Nicholls iD, Anna J Warren, Simon E Ward iD, Gwyndaf Evans, Fei Long, Garib N Murshudov iD, Ramona Duman, Benjamin D Bax

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252111688 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Harry Morgan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medicines Discovery Institute, Cardiff University, Cardiff CF10 3AT, UK. Hauptthemen laut MEDLINE: DNA Topoisomerases, Type II, DNA Cleavage. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medicines Discovery Institute/Diamond Light Source, Ada Lovelace Centre, part of the Science and Technology Facilities Council (STFC), part of UK Research and Innovation (UKRI), BBSRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

One of the challenges for experimental structural biology in the 21st century is to see chemical reactions happen. Staphylococcus aureus (S. aureus) DNA gyrase is a type IIA topoisomerase that can create temporary double-stranded DNA breaks to regulate DNA topology. Drugs, such as gepotidacin, zoliflodacin and the quinolone moxifloxacin, can stabilize these normally transient DNA strand breaks and kill bacteria. Crystal structures of uncleaved DNA with a gepotidacin precursor (2.1 Å GSK2999423) or with doubly cleaved DNA and zoliflodacin (or with its progenitor QPT-1) have been solved in the same P61 space-group (a = b ≈ 93 Å, c ≈ 412 Å). This suggests that it may be possible to observe the two DNA cleavage steps (and two DNA-religation steps) in this P61 space-group. Here, a 2.58 Å anomalous manganese dataset in this crystal form is solved, and four previous crystal structures (1.98 Å, 2.1 Å, 2.5 Å and 2.65 Å) in this crystal form are re-refined to clarify crystal contacts. The structures clearly suggest a single moving metal mechanism—presented in an accompanying (second) paper. A previously published 2.98 Å structure of a yeast topoisomerase II, which has static disorder around a crystallographic twofold axis, was published as containing two metals at one active site. Re-refined coordinates of this 2.98 Å yeast structure are consistent with other type IIA topoisomerase structures in only having one metal ion at each of the two different active sites.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA Topoisomerases, Type IIDNA CleavageBinding SitesCrystallography, X-RayOxazolidinonesStaphylococcus aureusTopoisomerase II InhibitorsAcenaphthenesModels, MolecularManganeseHeterocyclic Compounds, 3-Ring

Stichwörter der Autor:innen

DNA cleavagegepotidacimnovel bacterial topoisomerase inhibitor (NBTI)spirocyclic pyrimidinetrione (SPT)type IIA topoisomerasezoliflodacin

Substanzen

DNA Topoisomerases, Type IIgepotidacinOxazolidinonesTopoisomerase II InhibitorsAcenaphthenesManganeseHeterocyclic Compounds, 3-Ring

Autor:innen und Institutionen

  • Medicines Discovery Institute, Cardiff University, Cardiff CF10 3AT, UK.
  • Diamond Light Source, Harwell Campus, Didcot, Oxfordshire OX11 0DE, UK.
  • Scientific Computing Department, UKRI Science and Technology Facilities Council, Harwell Campus, Didcot, Oxfordshire OX11 0DE, UK.
  • MRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.

ORCID-Profile: Harry Morgan, Robert A Nicholls, Simon E Ward, Garib N Murshudov

Förderung

  • Medicines Discovery Institute/Diamond Light Source
  • Ada Lovelace Centre, part of the Science and Technology Facilities Council (STFC), part of UK Research and Innovation (UKRI)
  • BBSRC

Zitieren

APA

Morgan, H., Nicholls, R. A., Warren, A. J., Ward, S. E., Evans, G., Long, F., Murshudov, G. N., Duman, R., & Bax, B. D. (2024). How Do Gepotidacin and Zoliflodacin Stabilize DNA Cleavage Complexes with Bacterial Type IIA Topoisomerases? 1. Experimental Definition of Metal Binding Sites. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111688

Vancouver

Morgan H, Nicholls RA, Warren AJ, Ward SE, Evans G, Long F, et al. How Do Gepotidacin and Zoliflodacin Stabilize DNA Cleavage Complexes with Bacterial Type IIA Topoisomerases? 1. Experimental Definition of Metal Binding Sites. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111688

BibTeX
@article{Morgan2024,
  author = {Morgan, Harry and Nicholls, Robert A and Warren, Anna J and Ward, Simon E and Evans, Gwyndaf and Long, Fei and Murshudov, Garib N and Duman, Ramona and Bax, Benjamin D},
  title = {How Do Gepotidacin and Zoliflodacin Stabilize DNA Cleavage Complexes with Bacterial Type IIA Topoisomerases? 1. Experimental Definition of Metal Binding Sites},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252111688}
}
Kostenlos starten →